New ways of diagnosing Creutzfeldt-Jakob disease are emerging

The diagnosis of Creutzfeldt-Jakob disease is based on clinical and electroencephalographic criteria. Surrogate markers in cerebrospinal fluid can also aid diagnosis. On page 577 Otto et al report that a highly sensitive serum assay for brain specific S100 protein can be used to distinguish Creutzfeldt-Jakob disease from other diseases which cause dementia (sensitivity 77.8%, and specificity 81.1%). New variant Creutzfeldt-Jakob disease is possibly related to the causative agent of bovine spongiform encephalopathy. In view of the public health implications, the accurate ascertainment of cases is vital but difficult. On p 593 da Silva et al describe using single photon emission computed tomography with HMPAO to identify two cases of new variant Creutzfeldt-Jakob disease. They stress that the tomography findings are not diagnostic, but that abnormalities particularly in the setting of normal electroencephalography or cerebral magnetic resonance imaging should raise the suspicion of new variant Creutzfeldt-Jakob disease. Highly specialised "diagnostic" techniques can then be targeted at these patients.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Single photon emission computed tomography in the identification of new variant Creutzfeldt-Jakob disease: case reports
Rajith de Silva, James Patterson, Donald Hadley, Aline Russell, Martin Turner, and Martin Zeidler
BMJ 1998 316: 593-594. [Extract] [Full Text] [PDF]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ